ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
1.140
+0.075 (7.04%)
At close: Nov 6, 2026, 4:00 PM EST
1.140
0.00 (-0.03%)
After-hours: Nov 6, 2026, 7:43 PM EST
ProKidney Market Cap
ProKidney has a market cap or net worth of $344.65 million as of November 6, 2026. It is the 16,878th most valuable company in the world and the 3,022nd biggest in the United States. Its market cap has decreased by 56.63% in one year.
Market Cap
344.65M
Enterprise Value
166.61M
1-Year Change
-56.63%
Global Rank
Country Rank
#3,022 United States
Category
ChartMarket Cap Chart
Since June 30, 2021, ProKidney's market cap has increased from $258.80M to $344.65M, an increase of 33.17%. That is a compound annual growth rate of 5.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 344.65M | -48.86% |
| Dec 31, 2025 | 673.90M | 36.72% |
| Dec 31, 2024 | 492.90M | 17.61% |
| Dec 29, 2023 | 419.10M | -73.75% |
| Dec 30, 2022 | 1.60B | 405.76% |
| Dec 31, 2021 | 315.70M | 21.99% |
| Jun 30, 2021 | 258.80M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fennec Pharmaceuticals | 360.84M |
| Atea Pharmaceuticals | 356.91M |
| Opus Genetics | 355.66M |
| TRex Bio | 349.99M |
| Galectin Therapeutics | 349.95M |
| Eikon Therapeutics | 347.20M |
| AgomAb Therapeutics NV | 340.30M |
| Alector | 339.51M |